AI-driven Healthcare Technology Company Triomics Completes $22 million Series B Funding Round, Led by Battery Ventures

BlockBeats News, May 28th, according to TechCrunch, Triomics, a startup developing an AI-driven platform to assist oncologists and administrators in automating tasks related to large-scale data, such as clinical trial matching and appointment preparation, has completed a $22 million Series B funding round.

This funding round was led by Battery Ventures, with existing investors Nexus Venture Partners, Lightspeed, Y Combinator, and other institutions participating in the investment.

This startup, founded in 2021, previously raised $15 million in a Series A round in mid-2024. Initially focused on helping doctors match patients with the most suitable clinical trials, Triomics has gradually expanded its platform capabilities with the advancement of Large Language Models (LLMs).

Over the past few years, Triomics has added a verifiable patient summary feature to its platform, allowing for the direct presentation of key information within the tools already used by clinicians, eliminating the need for frequent application switching.

Click the original article link below to join the BlockBeats · Feishu AI News Channel and receive real-time monitoring of global AI trends and news 24/7.